Valuation : Orion Oyj

Market Cap 11.14B 12.91B 10.48B 9.54B 17.95B 1,225B 18.04B 124B 48.2B 623B 48.47B 47.42B 2,067B P/E 2026 *
19.7x
P/E 2027 * 16.9x
Enterprise Value 11.05B 12.81B 10.39B 9.47B 17.8B 1,215B 17.9B 123B 47.81B 618B 48.08B 47.04B 2,050B EV / Sales 2026 *
5.27x
EV / Sales 2027 * 4.56x
Free-Float
90.5%
Yield 2026 *
2.46%
Yield 2027 * 2.74%
1 day+0.28%
1 week-1.67%
Current month+0.44%
1 month+0.25%
3 months+16.67%
6 months+18.14%
Current year+24.82%
1 week 78.8
Extreme 78.8
81.2
1 month 76.8
Extreme 76.8
82.8
Current year 62.7
Extreme 62.7
82.8
1 year 56.5
Extreme 56.5
82.8
3 years 31.86
Extreme 31.86
82.8
5 years 31.86
Extreme 31.86
82.8
10 years 22.57
Extreme 22.57
82.8
Manager TitleAgeSince
Chief Executive Officer 59 2022-10-31
Director of Finance/CFO 50 2024-04-30
Chief Operating Officer 46 2021-12-31
Director TitleAgeSince
Director/Board Member 63 2017-03-21
Director/Board Member 65 2017-03-21
Director/Board Member 66 2020-05-05
Date Insider Type Main position Quantity % Market Cap. Importance
8/8/25 Sell

Chief Operating Officer

4,000 0.0122%
8/4/25 Sell

Executive/Senior Manager

71 0.0002%
8/4/25 Sell

Executive/Senior Manager

724 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
+0.44%-1.67%+17.70%+108.15% 12.93B
+0.57%-5.81%+58.06%+108.58% 1,031B
+1.46%-1.48%+51.13%+67.68% 641B
+1.28%-2.53%+22.25%+74.81% 453B
-1.50%-7.04%+33.55%+33.94% 349B
+6.25%+2.04%+28.97%+46.57% 290B
-0.07%-4.12%+0.95%+11.79% 252B
+0.65%-2.38%+50.46%+68.17% 232B
+0.51%-4.52%-19.50%-54.83% 201B
+1.57%-0.41%+31.45%+93.29% 181B
Average +1.00%-2.68%+27.50%+55.82% 364.27B
Weighted average by Cap. +1.00%-3.96%+37.55%+66.07%

Financials

2026 *2027 *
Net sales 2.1B 2.43B 1.97B 1.8B 3.38B 231B 3.4B 23.31B 9.07B 117B 9.12B 8.93B 389B 2.37B 2.74B 2.23B 2.03B 3.81B 260B 3.83B 26.32B 10.24B 132B 10.3B 10.08B 439B
Net income 564M 654M 531M 484M 910M 62.11B 915M 6.28B 2.44B 31.59B 2.46B 2.4B 105B 660M 766M 621M 566M 1.06B 72.66B 1.07B 7.34B 2.86B 36.96B 2.87B 2.81B 123B
Net Debt -89.76M -104M -84.43M -76.92M -145M -9.88B -145M -998M -389M -5.02B -391M -382M -16.66B -333M -386M -313M -285M -537M -36.63B -539M -3.7B -1.44B -18.63B -1.45B -1.42B -61.79B
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,000
Date Price Change Volume
26-09-01 79.45 +0.44% 247,933
26-08-31 €79.10 -0.94% 261,538
26-08-28 €79.85 +0.57% 181,644
26-08-27 €79.40 -0.87% 107,817
26-08-26 €80.10 -0.87% 82,982
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
79.10EUR
Average target price
76.67EUR
Spread / Average Target
-3.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ORNBV Stock